Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (51-60 of 752) with videos related to

Pageof 76
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|July 18, 2023
Cardiovascular events in patients treated with bempedoic acid vs. placebo: systematic review and meta-analysisDavid Mutschlechner, Maximilian Tscharre, Kurt Huber, et al.
Fundamental & Clinical Pharmacology|September 8, 2011
Pharmacokinetic basis of the antiplatelet action of prasugrelKarsten Schrör, Jolanta M Siller-Matula, Kurt Huber
Current Pharmaceutical Design|February 1, 2012
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agentsBurak Pamukcu, Kurt Huber, Gregory Y H Lip
Heart (British Cardiac Society)|December 30, 2010
New anticoagulant agents in acute coronary syndromesThomas Höchtl, Serdar Farhan, Johann Wojta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Guideline recommendations for cangrelor should be upgraded: pros and consGeorge Dangas, Johny Nicolas, Paul Harbich, et al.
Fundamental & Clinical Pharmacology|August 12, 2011
Antiplatelet function variability in clopidogrel-treated patients: need for new antiplatelet agentsThomas Höchtl, Iannis Tentzeris, Karsten Schrör, et al.
Nature Reviews. Drug Discovery|June 2, 2009
PrasugrelKurt Huber, Uma Yasothan, Bashar Hamad, et al.
Thrombosis and Haemostasis|September 20, 2013
Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapyFrancisco Marín, Kurt Huber, Gregory Y H Lip
European Heart Journal|January 3, 2022
The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart diseaseSusanna Price, Jason Katz, Christoph C Kaufmann, et al.
European Heart Journal. Acute Cardiovascular Care|March 29, 2021
The ACVC transatlantic collaboration: an initiative for exchange of knowledge and scienceSteen Dalby Kristensen, Kurt Huber, Konstantin Krychtiuk, et al.
Pageof 76

Showing results (51-60 of 752) with videos related to

Sort By:
Pageof 76
European Heart Journal. Cardiovascular Pharmacotherapy|July 18, 2023
Cardiovascular events in patients treated with bempedoic acid vs. placebo: systematic review and meta-analysisDavid Mutschlechner, Maximilian Tscharre, Kurt Huber, et al.
Fundamental & Clinical Pharmacology|September 8, 2011
Pharmacokinetic basis of the antiplatelet action of prasugrelKarsten Schrör, Jolanta M Siller-Matula, Kurt Huber
Current Pharmaceutical Design|February 1, 2012
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agentsBurak Pamukcu, Kurt Huber, Gregory Y H Lip
Heart (British Cardiac Society)|December 30, 2010
New anticoagulant agents in acute coronary syndromesThomas Höchtl, Serdar Farhan, Johann Wojta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Guideline recommendations for cangrelor should be upgraded: pros and consGeorge Dangas, Johny Nicolas, Paul Harbich, et al.
Fundamental & Clinical Pharmacology|August 12, 2011
Antiplatelet function variability in clopidogrel-treated patients: need for new antiplatelet agentsThomas Höchtl, Iannis Tentzeris, Karsten Schrör, et al.
Nature Reviews. Drug Discovery|June 2, 2009
PrasugrelKurt Huber, Uma Yasothan, Bashar Hamad, et al.
Thrombosis and Haemostasis|September 20, 2013
Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapyFrancisco Marín, Kurt Huber, Gregory Y H Lip
European Heart Journal|January 3, 2022
The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart diseaseSusanna Price, Jason Katz, Christoph C Kaufmann, et al.
European Heart Journal. Acute Cardiovascular Care|March 29, 2021
The ACVC transatlantic collaboration: an initiative for exchange of knowledge and scienceSteen Dalby Kristensen, Kurt Huber, Konstantin Krychtiuk, et al.
Pageof 76